Obama Unveils Brain Project

Starting in 2014, the federally funded initiative will seek to develop new technologies capable of mapping the activity in the human brain.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

NIH Director Francis Collins and President Barack Obama announcing the BRAIN initiativeWIKIMEDIA, CHUCK KENNEDYPresident Barack Obama yesterday (April 2) officially announced plans for a large-scale, government-backed research project to map the human brain, starting with an initial $100 million in federal funds for the development of new technologies that will enable the investigation of how millions of individual brain cells interact, reported BBC News.

Known as Brain Research through Advancing Innovative Neurotechnologies (BRAIN), the initiative is designed to have the same transformative effect on brain research—and on our understanding of various brain diseases—as the Human Genome Project did for genetics research. It will begin next year, led by three government agencies: the National Institutes of Health (NIH), The Defense Advanced Research Projects Agency (Darpa) and the National Science Foundation (NSF). A working group at the NIH—headed by Cornelia Bargmann of The Rockefeller University and William Newsome of Stanford University—will devise a plan of action, specific goals, and estimates of specific future budgets, reported The New York Times.

Private institutions, including the Allen Institute for Brain Science, the Howard Hughes Medical Institute, the Kavli Foundation, and the Salk Institute for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies